BridgeBio Pharma, Inc. (BBIO)

68.31 +0.40 (+0.59%) USD  |  NASDAQ  |  Feb 24, 16:00
70.14 +1.83 (+2.68%) After-Hours: 20:00
More

BridgeBio Pharma Change in Payables and Accrued Expense (Quarterly)

Change in Payables and Accrued Expense (Quarterly) Chart

View Change in Payables and Accrued Expense (Quarterly) for BBIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Change in Payables and Accrued Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years

View Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Change in Payables and Accrued Expense (Quarterly) Benchmarks

View Change in Payables and Accrued Expense (Quarterly) Benchmarks
Start Trial
Insmed, Inc. Upgrade
Mirum Pharmaceuticals, Inc. Upgrade
Cogent Biosciences, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Sarepta Therapeutics, Inc. Upgrade